Related Experiment Video
Updated: Aug 6, 2026
08:21
A Two-Dimensional Organoid Culture on Invasin or Basement Membrane Extract to Study Host-Bacteria Interactions
Published on: March 13, 2026
Engineering Organoid Platforms for Pathogenesis Research
Xiaolu Han1, Jun Zhang1, Jiahui Bai1
1National Key Laboratory of Advanced Biotechnology, Academy of Military Medical Sciences, 100071 Beijing, China.
Research (Washington, D.C.)
|August 5, 2026
Summary
Organoid technology offers human-relevant models for studying infectious diseases. These advanced in vitro systems improve our understanding of host-pathogen interactions and aid in developing new antiviral drugs and vaccines.
Area of Science:
- Biomedical research
- Pathogen studies
- Infectious disease modeling
Background:
- Emerging infectious diseases pose significant global health threats.
- There is a critical need for accurate, human-relevant infection models.
- Organoid technology recapitulates human tissue architecture and microenvironments in vitro.
Purpose of the Study:
- To review the development and refinement of organoid-based infection models.
- To evaluate strategies for enhancing organoid models for pathogen research.
- To assess the translational utility of organoids in drug screening and vaccine assessment.
Main Methods:
- Systematic examination of organoid development strategies (stem cell source, ECM, culture systems).
- Integration of organoids with advanced engineering (co-culture, CRISPR, organ-on-a-chip, 3D bioprinting).
- Evaluation of organoids for antiviral screening and vaccine preclinical assessment.
Main Results:
- Organoid models, including respiratory, intestinal, and neural types, are robustly generated.
- These models enable investigation of viral tropism, infection kinetics, and immune responses.
- Integrated organoid platforms enhance biomimicry, experimental control, and scalability.
Conclusions:
- Organoids have evolved into physiologically informed platforms for studying host-pathogen interactions.
- Organoid technology advances our understanding of emerging pathogens and enhances global preparedness.
- Overcoming bottlenecks is key for clinical translation of organoid applications.
